Oral Answers to Questions

Scott Mann Excerpts

Tuesday 16th June 2020 Commons Chamber

[Amanda Solloway]

We welcome inward investment in the UK’s civil nuclear sector. All investment involving critical infrastructure is subject to thorough scrutiny. Foreign investment and an active competitive economy are key to the UK’s growth. The UK wants a modern and mature relationship with China based on mutual respect and trust.

[Scott Mann (North Cornwall) (Con)]

What steps his Department is taking to support vaccine manufacturing and the UK life sciences sector.

[The Secretary of State for Business, Energy and Industrial Strategy (Alok Sharma)]

We have set up a vaccines taskforce to lead and co-ordinate all the Government’s activities to develop and manufacture a coronavirus vaccine. As part of that, we are investing £93 million in a vaccine manufacturing innovation centre, which will be completed 12 months ahead of schedule, by summer 2021. We are also funding a rapid deployment facility, which will be able to begin manufacturing vaccines at scale from August this year.

[Scott Mann]

Ultimately, throughout this process, we are in the hands of our brilliant scientists. I welcome the Secretary of State’s statement on what he is doing to accelerate opening the vaccine manufacturing innovation centre by next summer, but what more can be done to ensure that we get on top of this disease and address it as early as we possibly can?

[Alok Sharma]

Of course, my hon. Friend will know that we are providing direct support to the vaccines being developed at Oxford University and Imperial College London. He may also be aware that the Imperial vaccine is now set to enter clinical human trials. We are also leading international efforts to support vaccine discovery and deployment.